pretuval grippe & erkältung filmtabletten
bayer (schweiz) ag - paracetamolum, pseudoephedrini hydrochloridum, dextromethorphanum - filmtabletten - paracetamolum 300 mg, pseudoephedrini hydrochloridum 30 mg, dextromethorphani hydrobromidum 20 mg corresp. dextromethorphanum 14.66 mg, lactosum monohydricum 120 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 3.17 mg, maydis amylum, povidonum k 30, magnesii stearas, Überzug: hypromellosum, ethylcellulosum, talcum, e 171, e 172 (flavum), e 172 (nigrum), aqua purificata, pro compresso obducto. - erkältungskrankheiten mit husten, fieber und schmerzen - synthetika
emend 80 mg kapseln
msd merck sharp & dohme ag - aprepitantum - kapseln - aprepitantum 80 mg, excipiens pro kapsel. - antiemetikum - synthetika
emend 125 mg kapseln
msd merck sharp & dohme ag - aprepitantum - kapseln - aprepitantum 125 mg, excipiens pro kapsel. - antiemetikum - synthetika
emend 40 mg kapseln
msd merck sharp & dohme ag - aprepitantum - kapseln - aprepitantum 40 mg, excipiens pro kapsel. - antiemetikum - synthetika
emend 165 mg kapseln
msd merck sharp & dohme ag - aprepitantum - kapseln - aprepitantum 165 mg, color.: e 132, excipiens pro kapsel. - antiemetikum - synthetika
ivemend 150 mg infusionspräparat
msd merck sharp & dohme ag - fosaprepitantum - infusionspräparat - vorbereitung cryodesiccata: fosaprepitantum 150 mg bis dimeglumini fosaprepitantum, dinatrii edetas, polysorbatum 80, lactosum, für glas. - antiemetikum - synthetika
rifadine 300 mg hartkapsel
sanofi belgium - rifampicin - hartkapsel - 300 mg - rifampicin 300 mg - rifampicin
rifadine 150 mg hartkapsel
sanofi belgium - rifampicin - hartkapsel - 150 mg - rifampicin 150 mg - rifampicin
rifadine 600 mg pulver und lösungsmittel zur herstellung einer infusionslösung
sanofi belgium - rifampicin - pulver und lösungsmittel zur herstellung einer infusionslösung - 600 mg - rifampicin 600 mg - rifampicin
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastische mittel - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.